...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Promissory Note

OT it is for such a small amount  I would not think it could be DM Self dealing comes to mind

Share
New Message
Please login to post a reply